14th Mar 2012 17:59
e-Therapeutics plc ("e-Therapeutics" or the "Company")
14 March 2012
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
The Company was informed on 13 March 2012 that, on that day, Oliver James, Non- executive Chairman, purchased 34,500 ordinary shares in the Company at 29.0p per share.
Professor James's resultant total holding is 98,000 ordinary shares representing 0.1% of the issued share capital of the Company which currently stands at 138,126,467 shares all carrying voting rights.
Contacts
e-Therapeutics plc Tel: +44 (0)79 0991 5068
Daniel Elger
Panmure Gordon (UK) Limited Tel: +44 (0)20 7459 3600
Andrew Burnett/ Fred Walsh
Related Shares:
ETX.L